Clinical, transcriptomic, and experimental data allow us to conceptualize hepatic ferroptosis as four interacting molecular modules: expansion of the labile pool of ferrous iron, enrichment of membranes with oxidizable polyunsaturated phospholipids, enzymatic and non-enzymatic lipid peroxidation, and failure of antioxidant defense.
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a widespread chronic liver disease that can progress from steatosis to steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma. Its pathogenesis involves lipotoxicity, iron metabolism disorders, and oxidative stress—the same three processes that underlie ferroptosis, an iron-dependent form of regulated cell death mediated by the peroxidation of membrane phospholipids. However, the question of whether ferroptosis is a universal mechanism underlying the progression of MASLD as a whole or a hallmark of a distinct subgroup of patients remains unresolved. Furthermore, no ferroptosis-targeted strategy has yet been tested in a biomarker-selected population. This review addresses precisely this gap. Clinical, transcriptomic, and experimental data allow us to conceptualize hepatic ferroptosis as four interacting molecular modules: expansion of the labile pool of ferrous iron, enrichment of membranes with oxidizable polyunsaturated phospholipids, enzymatic and non-enzymatic lipid peroxidation, and failure of antioxidant defense. An imbalance in these modules leads to the accumulation of phospholipid hydroperoxides, disruption of membrane integrity, and immunogenic hepatocyte death with the release of signals that promote inflammation and fibrogenesis. At the same time, ferroptosis exhibits pronounced cellular and contextual specificity. It exerts a damaging effect on hepatocytes and sinusoidal endothelial cells, enhances inflammation in macrophages, but exerts an antifibrotic effect in activated stellate cells and immunosuppressive effects in lymphocytes. In this regard, known anti-ferroptotic strategies (iron chelation, inhibition of long-chain acyl-coenzyme A (CoA) synthase 4 (ACSL4)-dependent incorporation of polyunsaturated fatty acids, use of lipid radical scavengers and vitamin E, and activation of protective antioxidant programs) retain their diagnostic and therapeutic potential only within the framework of a molecularly and cell-stratified approach.
Metabolic dysfunction-associated steatotic liver disease (MASLD) impacts >30% of the global population. Its progression to metabolic dysfunction-associated steatohepatitis and liver fibrosis is the primary determinant for cirrhosis and hepatocellular carcinoma. Ferroptosis depends on iron and is driven by lipid peroxid...
Xiang Tao, Mei Liu· International Journal of Mol...· 0 citations
This review aims to provide a comprehensive overview of the current molecular pathways and regulatory mechanisms underlying iron homeostasis and intracellular compartmentation in liver biology, emphasizing the roles of ferroptosis in several liver diseases.
Peng Cao, Pei-Jian He, Kuo Du et al.· Hepatology Communications· 0 citations
Metabolic dysfunction-associated steatotic liver disease (MASLD) has attracted considerable global concern. Physical inactivity, excessive caloric intake and unhealthy lifestyle factors, have contributed to its development. Obesity and metabolic disorders are strongly correlated with MASLD. It is a complex condition ma...
R. Sharma, Abhilasha Tiwari, Parveen Kumar et al.· Egyptian Liver Journal· 0 citations
Abstract Steatotic liver disease (SLD) encompasses a broad spectrum of disorders influenced by metabolic dysfunction, alcohol use, and other cofactors. The updated classification of metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-associated liver disease (ALD), along with the recognition of...
Afolabi Akanbi, K. Bridle, D. Crawford· Bioscience Reports· 0 citations
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide and a leading cause of advanced liver fibrosis, cirrhosis, and hepatocellular carcinoma. The disease develops through the interaction of multiple interconnected pathophysiological mechanisms, including in...
T. Radosavljević, J. Djuretić, M. Branković et al.· Antioxidants· 0 citations
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death that is driven by lipid peroxidation. In the past decade, it has emerged as a core pathogenic mechanism in a wide range of human diseases, such as neurodegenerative disorders, cardiovascular disease, cancer, and notably, reproductive dysfuncti...
P. Oyedokun, V. Ashonibare, T. Akhigbe et al.· Molecular Biomedicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.